Open AccessPB2097: ZANUBRUTINIB PLUS RITUXIMAB FOR THE TREATMENT OF ELDERLY UNFIT PATIENTS WITH PREVIOUSLY UNTREATED DIFFUSE LARGE‐B CELL LYMPHOMA
Author(s) -
Bai J.F.,
Li J. T.,
Feng R.,
Qian L.,
Yin J.,
Liu H.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000851220.50282.7c
Subject(s) - rituximab , medicine , diffuse large b cell lymphoma , regimen , bruton's tyrosine kinase , lymphoma , performance status , oncology , gastroenterology , chemotherapy , tyrosine kinase , receptor